Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Wyllie

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Science Translational Medicine|February 4, 2012
The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasisSusan Wyllie, Stephen Patterson, Laste Stojanovski, et al.
Plos Pathogens|November 5, 2016
Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in LeishmaniaSusan Wyllie, Adam J Roberts, Suzanne Norval, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2015
Pentacyclic nitrofurans that rapidly kill nifurtimox-resistant trypanosomesDavid F Bruhn, Susan Wyllie, Adaris Rodríguez-Cortés, et al.
Lancet (London, England)|August 28, 2015
Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment- resistant kala-azar?Meghan Perry, Susan Wyllie, Vijay Prajapati, et al.
Elife|May 25, 2016
The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasisStephen Patterson, Susan Wyllie, Suzanne Norval, et al.
ACS Infectious Diseases|June 3, 2025
The Thienopyrimidinone Gamhépathiopine Targets the Q<sub>O</sub> Site of <i>Plasmodium falciparum</i> Cytochrome <i>b</i>Natalie Wiedemar, Rachel Milne, Sandra Carvalho, et al.
ACS Infectious Diseases|September 29, 2018
Development of Chemical Proteomics for the Folateome and Analysis of the Kinetoplastid FolateomeLauren A Webster, Michael Thomas, Michael Urbaniak, et al.
Mbio|August 27, 2024
ResMAP-a saturation mutagenesis platform enabling parallel profiling of target-specific resistance-conferring mutations in <i>Plasmodium</i>Richard J Wall, Stuart A MacGowan, Irene Hallyburton, et al.
ACS Infectious Diseases|June 17, 2026
Synthesis and Evaluation of Nitroheterocyclic Aromatic Adamantanohydrazones with Trypanocidal Activity. Part IIIAngeliki-Sofia Foscolos, Konstantina Stavropoulou, Nuno Santarém, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2018
Clinical and veterinary trypanocidal benzoxaboroles target CPSF3Richard J Wall, Eva Rico, Iva Lukac, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Science Translational Medicine|February 4, 2012
The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasisSusan Wyllie, Stephen Patterson, Laste Stojanovski, et al.
Plos Pathogens|November 5, 2016
Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in LeishmaniaSusan Wyllie, Adam J Roberts, Suzanne Norval, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2015
Pentacyclic nitrofurans that rapidly kill nifurtimox-resistant trypanosomesDavid F Bruhn, Susan Wyllie, Adaris Rodríguez-Cortés, et al.
Lancet (London, England)|August 28, 2015
Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment- resistant kala-azar?Meghan Perry, Susan Wyllie, Vijay Prajapati, et al.
Elife|May 25, 2016
The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasisStephen Patterson, Susan Wyllie, Suzanne Norval, et al.
ACS Infectious Diseases|June 3, 2025
The Thienopyrimidinone Gamhépathiopine Targets the Q<sub>O</sub> Site of <i>Plasmodium falciparum</i> Cytochrome <i>b</i>Natalie Wiedemar, Rachel Milne, Sandra Carvalho, et al.
ACS Infectious Diseases|September 29, 2018
Development of Chemical Proteomics for the Folateome and Analysis of the Kinetoplastid FolateomeLauren A Webster, Michael Thomas, Michael Urbaniak, et al.
Mbio|August 27, 2024
ResMAP-a saturation mutagenesis platform enabling parallel profiling of target-specific resistance-conferring mutations in <i>Plasmodium</i>Richard J Wall, Stuart A MacGowan, Irene Hallyburton, et al.
ACS Infectious Diseases|June 17, 2026
Synthesis and Evaluation of Nitroheterocyclic Aromatic Adamantanohydrazones with Trypanocidal Activity. Part IIIAngeliki-Sofia Foscolos, Konstantina Stavropoulou, Nuno Santarém, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2018
Clinical and veterinary trypanocidal benzoxaboroles target CPSF3Richard J Wall, Eva Rico, Iva Lukac, et al.
Pageof 10